Login:
 
Bland P. Gene variants associated with increased risk of congenital heart defects with SSRI use. Practitioner 2017;261 (1803):10

Gene variants associated with increased risk of congenital heart defects with SSRI use

24 Apr 2017Pais-up subscribers

Common variants in genes related to folic acid, homocysteine and glutathione/transsulfuration metabolic pathways are associated with an increased risk of congenital heart disease in the offspring of women who take SSRIs in the periconceptual period, a US case control study has found.

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .